More News

24 Jul 2020 Menarini Group and Radius Health Announce Global License Agreement for the Development and Commercialization of Elacestrant
23 Jul 2020 G1 Therapeutics Announces License Agreement for Lerociclib
22 Jul 2020 Qualigen Therapeutics Signs Exclusive License Agreement with the University of Louisville for RAS Interaction Inhibitor Drug Candidates
21 Jul 2020 UNION therapeutics announces acquisition of PDE4i compound class from LEO Pharma with oral lead candidate (orismilast) in Phase 2
21 Jul 2020 Gilead Sciences Secures Exclusive Option to Acquire Tizona Therapeutics for $300 Million
21 Jul 2020 Jnana Therapeutics Enters Collaboration with Roche to Discover Novel Medicines that Target Key Regulators of Cellular Metabolism to Treat Immune-Mediated and Neurological Diseases
21 Jul 2020 Tubulis Raises €10.7 M Series A to Advance Development of a New Generation of Antibody-Drug Conjugates
18 Jul 2020 Inozyme Pharma Acquires ENPP1 Deficiency Program Assets from Alexion Pharmaceuticals
14 Jul 2020 Sanofi And MD Anderson Announce Strategic Collaboration To Accelerate Oncology Research And Development
14 Jul 2020 Blueprint Medicines Announces Global Collaboration with Roche to Develop and Commercialize Pralsetinib for Patients with RET-Altered Cancers
13 Jul 2020 Dewpoint Therapeutics Collaborates with Merck to Evaluate Novel Approach for the Treatment of HIV
09 Jul 2020 Zymeworks Announces New Multispecific Antibody Collaboration with Merck
09 Jul 2020 ProteinQure Collaborates with AstraZeneca to Design Novel Peptide Therapeutics
09 Jul 2020 Foghorn® Therapeutics Announces Collaboration with Merck to Discover and Develop Novel Oncology Therapeutics Against Transcription Factor Target
07 Jul 2020 Numab Therapeutics and Boehringer Ingelheim Enter into Collaboration to Develop Multi-specific Antibody Therapeutics for Cancer and Retinal Diseases
07 Jul 2020 Unum Therapeutics Inc. Announces Acquisition of Kiq LLC
06 Jul 2020 Dragonfly Therapeutics Announces New Research Collaboration with Bristol Myers Squibb to Develop Novel Therapeutic Candidates for Multiple Sclerosis and Neuro-inflammation Target
02 Jul 2020 Merck and Ridgeback Bio Announce Closing of Collaboration and Licensing Transaction
01 Jul 2020 Aligos Therapeutics and KU Leuven Announce Collaboration for the Development of a Therapeutic Candidate Targeting Coronavirus
01 Jul 2020 Carmine Therapeutics and Takeda Collaborate to Discover and Develop Rare Disease Gene Therapies Using Novel Red Blood Cell Extracellular Vesicles Platform
30 Jun 2020 Bioasis and Chiesi Group Announce Rare Diseases Strategic Alliance
29 Jun 2020 VITRAC Therapeutics Initiated Global Clinical Development of VIC-1911, licensed from Taiho Pharmaceutical
26 Jun 2020 Sosei Heptares and AbbVie Announce New Discovery Collaboration Targeting Inflammatory Diseases
24 Jun 2020 Yumanity Therapeutics Announces Strategic Research Collaboration and License Agreement with Merck Focused on Accelerating the Development of New Treatments for Neurodegenerative Diseases
24 Jun 2020 La Jolla Pharmaceutical Company to Acquire Tetraphase Pharmaceuticals, Inc.

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2020 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up